BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Beshlawy A, El Accaoui R, Abd El-Sattar M, Gamal El-Deen MH, Youssry I, Shaheen N, Hamdy M, El-Ghamrawy M, Taher A. Effect of L-carnitine on the physical fitness of thalassemic patients. Ann Hematol. 2007;86:31-34. [PMID: 17031691 DOI: 10.1007/s00277-006-0181-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Sohn EY, Kato R, Noetzli LJ, Gera A, Coates T, Harmatz P, Keens TG, Wood JC. Exercise performance in thalassemia major: Correlation with cardiac iron burden. Am J Hematol 2013;88:193-7. [DOI: 10.1002/ajh.23370] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
2 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
3 Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128:281-308. [PMID: 23775258 DOI: 10.1161/cir.0b013e31829b2be6] [Cited by in Crossref: 187] [Cited by in F6Publishing: 71] [Article Influence: 20.8] [Reference Citation Analysis]
4 Kraemer WJ, Volek JS, Dunn-lewis C. L-Carnitine Supplementation: Influence upon Physiological Function. Current Sports Medicine Reports 2008;7:218-23. [DOI: 10.1249/jsr.0b013e318180735c] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
5 Merchant R, Jain A, Udani A, Puri V, Kotian M. L-carnitine in beta thalassemia. Indian Pediatr 2010;47:165-7. [PMID: 19430074 DOI: 10.1007/s13312-010-0025-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Hamed EM, Meabed MH, Aly UF, Hussein RRS. Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia. Curr Drug Targets 2019;20:1603-23. [PMID: 31362654 DOI: 10.2174/1389450120666190726155733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Sayed-Ahmed MM. Role of carnitine in cancer chemotherapy-induced multiple organ toxicity. Saudi Pharm J 2010;18:195-206. [PMID: 23960728 DOI: 10.1016/j.jsps.2010.07.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
8 Vatanavicharn N, Yamada K, Aoyama Y, Fukao T, Densupsoontorn N, Jirapinyo P, Sathienkijkanchai A, Yamaguchi S, Wasant P. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response. Brain Dev 2015;37:698-703. [PMID: 25459972 DOI: 10.1016/j.braindev.2014.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
9 Shahidi M, Hashemi SR, Fattahi N, Roshani D, Vahedi S, Sharifi P, Moradveisi B. The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia. J Pediatr Hematol Oncol 2020;42:386-90. [PMID: 32555029 DOI: 10.1097/MPH.0000000000001850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Olalla-Saad ST. Fermented papaya preparation for β-thalassemia? Expert Rev Hematol 2010;3:265-8. [PMID: 21082979 DOI: 10.1586/ehm.10.23] [Reference Citation Analysis]
11 Kumar Sarker S, Islam MT, Sarower Bhuyan G, Sultana N, Begum MN, Al Mahmud-Un-Nabi M, Al Noman Howladar MA, Farhana Dipta T, Muraduzzaman AKM, Kashfi Qadri S, Shirin T, Sadiya S, Hussain M, Ahmed Khan W, Akhteruzzaman S, Saleheen Qadri S, Qadri F, Mannoor K. Impaired acylcarnitine profile in transfusion-dependent beta-thalassemia major patients in Bangladesh. J Adv Res 2018;12:55-66. [PMID: 30046479 DOI: 10.1016/j.jare.2018.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]